@article{6cecbe7d32c4476cb7c071d534f17f52,
title = "Non-Small Cell Lung Cancer, Version 3.2022",
abstract = "NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) for Non-Small Cell Lung Cancer (NSCLC) provide recommended management for patients with NSCLC, including diagnosis, primary treatment, surveillance for relapse, and subsequent treatment. Patients with metastatic lung cancer who are eligible for targeted therapies or immunotherapies are now surviving longer. This selection from the NCCN Guidelines for NSCLC focuses on targeted therapies for patients with metastatic NSCLC and actionable mutations.",
keywords = "Carcinoma, Non-Small-Cell Lung/diagnosis, Humans, Immunotherapy, Lung Neoplasms/diagnosis, Medical Oncology, Neoplasm Recurrence, Local",
author = "Ettinger, {David S.} and Wood, {Douglas E.} and Aisner, {Dara L.} and Wallace Akerley and Bauman, {Jessica R.} and Ankit Bharat and Bruno, {Debora S.} and Chang, {Joe Y.} and Chirieac, {Lucian R.} and D'Amico, {Thomas A.} and Malcolm DeCamp and Dilling, {Thomas J.} and Jonathan Dowell and Scott Gettinger and Grotz, {Travis E.} and Gubens, {Matthew A.} and Aparna Hegde and Lackner, {Rudy P.} and Michael Lanuti and Jules Lin and Loo, {Billy W.} and Lovly, {Christine M.} and Fabien Maldonado and Erminia Massarelli and Daniel Morgensztern and Thomas Ng and Otterson, {Gregory A.} and Pacheco, {Jose M.} and Patel, {Sandip P.} and Riely, {Gregory J.} and Jonathan Riess and Schild, {Steven E.} and Shapiro, {Theresa A.} and Singh, {Aditi P.} and James Stevenson and Alda Tam and Tawee Tanvetyanon and Jane Yanagawa and Yang, {Stephen C.} and Edwin Yau and Kristina Gregory and Miranda Hughes",
note = "Publisher Copyright: {\textcopyright} 2022 Harborside Press. All rights reserved.",
year = "2022",
month = may,
doi = "10.6004/jnccn.2022.0025",
language = "English",
volume = "20",
pages = "497--530",
journal = "Journal of the National Comprehensive Cancer Network : JNCCN",
issn = "1540-1405",
publisher = "Harborside Press",
number = "5",
}